122 related articles for article (PubMed ID: 15803584)
1. FDA improves safety of human cells and tissues.
FDA Consum; 2005; 39(1):5. PubMed ID: 15803584
[No Abstract] [Full Text] [Related]
2. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 May; 69(101):29785-834. PubMed ID: 15160713
[TBL] [Abstract][Full Text] [Related]
3. FDA 'fails to keep track of transplant patients'.
Wadman M
Nature; 1998 Jan; 391(6665):315. PubMed ID: 9450732
[No Abstract] [Full Text] [Related]
4. Clarification of FDA and The Joint Commission reporting requirements for US tissue recipient adverse reactions.
Khoie T; Zinderman CE; Solomon R; Wise RP; Lee KC; Nether K
Cell Tissue Bank; 2008 Mar; 9(1):67-8. PubMed ID: 17473991
[No Abstract] [Full Text] [Related]
5. Safeguarding human tissue transplants.
Henkel J
FDA Consum; 1994 Sep; 28(7):9-13. PubMed ID: 10139008
[TBL] [Abstract][Full Text] [Related]
6. Human cells, tissues, and cellular and tissue-based products; donor screening and testing, and related labeling. Interim final rule; opportunity for public comment.
Food and Drug Administration, HHS
Fed Regist; 2005 May; 70(100):29949-52. PubMed ID: 15915582
[TBL] [Abstract][Full Text] [Related]
7. Human tissues and reproductive cloning: new technologies challenge FDA.
Merrill RA
Houst J Health Law Policy; 2002; 3(1):1-82. PubMed ID: 15712415
[No Abstract] [Full Text] [Related]
8. Human tissue intended for transplantation--FDA. Interim rule; opportunity for public comment.
Fed Regist; 1993 Dec; 58(238):65514-21. PubMed ID: 10131341
[TBL] [Abstract][Full Text] [Related]
9. Overview of FDA regulation of human cellular and tissue-based products.
Wells MA
Food Drug Law J; 1997; 52(4):401-8. PubMed ID: 10346672
[No Abstract] [Full Text] [Related]
10. Managing a tissue recall in a large academic hospital.
Steelman VM; Schlueter AJ
Transfusion; 2007 May; 47(5):927-34. PubMed ID: 17465960
[TBL] [Abstract][Full Text] [Related]
11. The regulation of human tissue in the United States: a regulatory and legislative analysis.
Williams MO
Food Drug Law J; 1997; 52(4):409-28. PubMed ID: 10346673
[No Abstract] [Full Text] [Related]
12. Brief report: investigation into recalled human tissue for transplantation--United States, 2005-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 May; 55(20):564-6. PubMed ID: 16723969
[TBL] [Abstract][Full Text] [Related]
13. The case for regulatory compliance of electronic medical records about human tissue intended for transplantation.
Carrier R
J Healthc Inf Manag; 2004; 18(4):61-6. PubMed ID: 15537136
[TBL] [Abstract][Full Text] [Related]
14. FDA regulation of human cloning: usurpation or statesmanship?
Merrill RA; Rose BJ
Harv J Law Technol; 2001; 15(1):85-148. PubMed ID: 15156886
[No Abstract] [Full Text] [Related]
15. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Interim final rule; opportunity for public comment.
Food and Drug Administration, HHS
Fed Regist; 2004 Jan; 69(17):3823-6. PubMed ID: 14968801
[TBL] [Abstract][Full Text] [Related]
16. Safety and FDA regulations for musculoskeletal allografts: perspective of an orthopaedic surgeon.
Joyce MJ
Clin Orthop Relat Res; 2005 Jun; (435):22-30. PubMed ID: 15930917
[TBL] [Abstract][Full Text] [Related]
17. Who are the watchdogs?
Miller C
RDH; 1990 May; 10(5):16-7. PubMed ID: 2217874
[No Abstract] [Full Text] [Related]
18. Burden of transplanting tissues.
Norman AC
J Oral Implantol; 2003; 29(5):211-2. PubMed ID: 14620682
[No Abstract] [Full Text] [Related]
19. Infections and human tissue transplants: review of FDA MedWatch reports 2001-2004.
Wang S; Zinderman C; Wise R; Braun M
Cell Tissue Bank; 2007; 8(3):211-9. PubMed ID: 17278013
[TBL] [Abstract][Full Text] [Related]
20. FDA symbolically stigmatizes gay donors with new rules.
AIDS Policy Law; 2005 May; 20(10):1, 4. PubMed ID: 15938004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
